Fuji Pharma Co 4554.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4554.T. It has been listed since 22 June 1995. In the fiscal year to 30 September 2025, it reported revenue of ¥51.68bn and net income of ¥3.00bn. At that date it held total assets of ¥93.63bn and shareholders' equity of ¥46.91bn.

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Takayuki IwaiChairman of the Board, Representative Director, since 2006
• Mr. Shuhei MoritaPresident, Chief Executive Officer, Representative Director, since 2016
• Mr. Toyoyuki KamideVice President, Toyama Plant Manager, Director, since 2007
• Mr. Satoshi SuzukiVice President, Chief Director of Business Strategy, Director, since 2022
• Mr. Atsuya MitsuhashiManaging Executive Officer, Director of Business Planning, since 2010
• Mr. Masayuki NaganawaManaging Executive Officer, Chief Director of Research and Development
• Mr. Takeshi SatoManaging Executive Officer
• Mr. Takashi FujisawaExecutive Officer, Director of Sales
• Mr. Takanori MatsuoExecutive Officer, Chief Director of Sales, since 2021
• Mr. Hiroshi UjiExecutive Officer, Director of Business Administration
• Mr. Yoshinari KanayamaExecutive Officer, Director of Research
• Ms. Sachiko MatsuyamaExecutive Officer, Director of Quality Control

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.